Hematologic Malignancy
Light Chain Deposition Disease
CI-CAN-00007951Explore in graph →
HematologicNon-malignant1 active trials
- NCIt
- C7727
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00007951Explore in graph →
Clinical trials
11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01728259 | First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD | terminated | Phase 1 | 18 | Barbara Ann Karmanos Cancer InstituteOTHER | 2 | May 9, 2023 | clinicaltrials |
Data updated 22 days agoSource updated May 9, 2023source: clinicaltrials